Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems
Other posts you may like
Discover how emka helps you to comply with regulatory guidance
Based in Falls Church, VA, USA
Discover our new myograph module and perfusion system!
Recent Advances in ECG Analysis for ProArrhythmia Risk Assessment: The Need to Read Between the Line
Download the presentation from Citox Lab (SOT 2019)